IMA CIK: 1835579

ImageneBio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
237
FY22:
160
FY23:
179
FY24:
12.5
FY25:
140
(positive)
Change from FY21 to FY25
millions USD
FY21:
11.4
FY22:
12.2
FY23:
13.4
FY24:
3.45
FY25:
12.7
Total assets
Change from FY21 to FY25
millions USD
FY21:
248
FY22:
172
FY23:
192
FY24:
15.9
FY25:
153

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
27.2
FY22:
21.5
FY23:
14.2
FY24:
17.2
FY25:
11.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
12.8
FY22:
3.79
FY23:
8.13
FY24:
0.24
FY25:
8.60
(positive)
Change from FY21 to FY25
millions USD
FY21:
208
FY22:
147
FY23:
170
FY24:
−161
FY25:
133
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
248
FY22:
172
FY23:
192
FY24:
–
FY25:
153

All amounts in millions USD Data source:SEC EDGAR